{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:42:24Z","timestamp":1787496144156,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.diagmicrobio.2019.05.017","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:39:37Z","timestamp":1559255977000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea"],"prefix":"10.1016","volume":"95","author":[{"given":"Jae-Hoon","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Sik","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Yeol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-In","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jeong","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinhye","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0005","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0010","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0020","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antifungal susceptibility testing of yeasts. 1st ed. CLSI supplement M60. Wayne, PA. Clinical and Laboratory Standards Institute 2017."},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/456878","article-title":"Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/dks482","article-title":"Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study","volume":"68","author":"Eschenauer","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis","volume":"58","author":"Fernandez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2015.05.009","article-title":"Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance","volume":"71","author":"Fernandez-Ruiz","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0045","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.02155-13","article-title":"Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011","volume":"58","author":"Guinea","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3343\/alm.2013.33.3.167","article-title":"In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values","volume":"33","author":"Jang","year":"2013","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/13693780903410386","article-title":"Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea","volume":"48","author":"Jung","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3343\/alm.2012.32.6.426","article-title":"Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea","volume":"32","author":"Jung","year":"2012","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0070","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc10514","article-title":"Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis","volume":"15","author":"Kett","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.diagmicrobio.2018.05.001","article-title":"Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study","volume":"92","author":"Ko","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jiac.2018.09.016","article-title":"Changing epidemiology of non-albicans candidemia in Korea","volume":"25","author":"Ko","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0095","doi-asserted-by":"crossref","first-page":"733 e1","DOI":"10.1016\/j.cmi.2016.05.008","article-title":"Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort","volume":"22","author":"Lopez-Cortes","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0105","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10096-015-2527-2","article-title":"Initial antifungal strategy does not correlate with mortality in patients with candidemia","volume":"35","author":"Murri","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0115","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10096-011-1455-z","article-title":"Insights into Candida tropicalis nosocomial infections and virulence factors","volume":"31","author":"Negri","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0125","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/JCM.01986-06","article-title":"Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0135","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0140","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.00195-16","article-title":"Propensity score analysis of the role of initial antifungal therapy in the outcome of Candida glabrata bloodstream infections","volume":"60","author":"Puig-Asensio","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0145","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","article-title":"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome","volume":"11","author":"Reboli","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0155","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1128\/JCM.41.12.5792-5793.2003","article-title":"Expression of plasma coagulase among pathogenic Candida species","volume":"41","author":"Rodrigues","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/mmy\/myv114","article-title":"Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region","volume":"54","author":"Tan","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmii.2016.08.015","article-title":"Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: an experience in a tertiary hospital in mid-Taiwan","volume":"51","author":"Tseng","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.05.017_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118770","article-title":"Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage","volume":"10","author":"Won","year":"2015","journal-title":"PLoS One"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319302548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319302548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:52:24Z","timestamp":1760003544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319302548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0732889319302548"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.05.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}